Boston Scientific Corp. (BSX)

38.16
0.30 0.78
NYSE : Health Technology
Prev Close 38.46
Open 38.22
Day Low/High 37.87 / 38.40
52 Wk Low/High 31.56 / 43.84
Volume 7.97M
Avg Volume 6.06M
Exchange NYSE
Shares Outstanding 1.39B
Market Cap 52.89B
EPS 1.20
P/E Ratio 38.35
Div & Yield N.A. (N.A)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Boston Scientific Corporation To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Boston Scientific Corporation To Contact The Firm

NEW YORK, April 25, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:BSX) of the June 24, 2019 deadline to seek the role of...

Johnson Fistel Announces Class Action Suit Against Boston Scientific Corporation (BSX); Encourages Investors To Contact The Firm For Additional Information

Johnson Fistel Announces Class Action Suit Against Boston Scientific Corporation (BSX); Encourages Investors To Contact The Firm For Additional Information

SAN DIEGO, April 25, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP reminds investors that a class action lawsuit has been filed against Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific") on behalf of all purchasers of...

Boston Scientific Announces Results For First Quarter 2019

Boston Scientific Announces Results For First Quarter 2019

MARLBOROUGH, Mass., April 24, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2.

Boston Scientific Receives FDA Approval For LOTUS Edge™ Aortic Valve System

Boston Scientific Receives FDA Approval For LOTUS Edge™ Aortic Valve System

Transcatheter Aortic Valve Replacement Technology for Patients with Severe Aortic Stenosis Designed to Minimize Paravalvular Leakage, Offer Controlled Delivery and Repositionability Post Deployment

Lifshitz & Miller LLP Announces Investigation Of Advanced Disposal Services, Inc., Boston Scientific Corporation, Cavco Industries, Inc., Evoqua Water Technologies Corp., HomeFed Corporation, KeyW Holding Corporation, Level Brands, Inc., And Nightstar Therapeutics Plc.

Lifshitz & Miller LLP Announces Investigation Of Advanced Disposal Services, Inc., Boston Scientific Corporation, Cavco Industries, Inc., Evoqua Water Technologies Corp., HomeFed Corporation, KeyW Holding Corporation, Level Brands, Inc., And Nightstar Therapeutics Plc.

NEW YORK, April 23, 2019 /PRNewswire/ -- Advanced Disposal Services, Inc. (ADSW) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of ADSW to Waste Management, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Boston Scientific Corporation - BSX

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Boston Scientific Corporation - BSX

NEW YORK, April 19, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX).

Edwards Lifesciences' Stock Jumps on Patent Dispute Settlement

Edwards Lifesciences' Stock Jumps on Patent Dispute Settlement

Shares jump nearly 8% following agreement to pay rival Boston Scientific Corp. 4180 million to settle long-standing patent disputes.

Shire, Abbott Labs May Pace Healthcare Stocks in 2019

Shire, Abbott Labs May Pace Healthcare Stocks in 2019

Healthcare has been the best performing sector of the market this year. Here are three buy-rated stocks to track now.

When Will the Pain End?: Cramer's 'Mad Money' Recap (Tuesday 11/27/18)

When Will the Pain End?: Cramer's 'Mad Money' Recap (Tuesday 11/27/18)

Jim Cramer says most - but not all - stocks are in a bear market. He talks about what's happening with Clorox, Coca-Cola, Verizon, Apple and more.

Analog Devices, MongoDB, Welltower: 'Mad Money' Lightning Round

Analog Devices, MongoDB, Welltower: 'Mad Money' Lightning Round

Jim Cramer takes a look at Analog Devices, MongoDB, Welltower, Ventas, Iridium Communications, Huntington Bancshares, Citigroup, Randgold Resources and more.

Boston Scientific to Buy Britain's BTG for $4.2 Billion

Boston Scientific to Buy Britain's BTG for $4.2 Billion

Boston Scientific offered $10.77 for each BTG share, valuing the company at $4.2 billion.

FAANGs, Retail, Housing, Boston Scientific & Renault - Five Things You Must Know

FAANGs, Retail, Housing, Boston Scientific & Renault - Five Things You Must Know

FAANG stocks are sliding into bear market territory, retail earnings dominate today's corporate calendar, housing starts and building permits will test US rate hike bets, Boston Scientific makes $4.2 billion U.K. play and Carlos Ghosn could be left by the roadside - Five Things You Must Know Before the Bell.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: Here's Why the Market Rally Has Staying Power

Jim Cramer: Here's Why the Market Rally Has Staying Power

For most of this year the market has been led by growth stocks.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

How Boston Scientific Call Prices Rose Eightfold

How Boston Scientific Call Prices Rose Eightfold

The Healthcare sector has seen a revitalization year-to-date, and these investors may have wanted to participate in a continued move higher, risking a fraction of the price of a share in the event they were 'late to the party.'

3 Biotech Stock Favorites to Bet on Today: Top Analysts

3 Biotech Stock Favorites to Bet on Today: Top Analysts

Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

The heart-implant manufacturer is down some 4% over two days, but is up 128% year to date.

Magellan Midstream, Xylem, Boston Scientific: 'Mad Money' Lightning Round

Magellan Midstream, Xylem, Boston Scientific: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Magellan Midstream Partners, Xylem, Boston Scientific, Karyopharm Thereapeutics, Iovance Biotherapeutics, Casella Waste Systems and more.

How to Handle the Fed: Cramer's 'Mad Money' Recap (Wednesday 6/13/18)

How to Handle the Fed: Cramer's 'Mad Money' Recap (Wednesday 6/13/18)

Jim Cramer says higher rates always trigger rotations. Here's what investors should expect.

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Jim Cramer and our other experts discuss the AT&T/Time Warner ruling, Alzheimer plays, and day traders risk.

Stryker Says Not in Talks to Buy Boston Scientific

Stryker Says Not in Talks to Buy Boston Scientific

The medical device firm issues an 8-K filing on the heels of a media report earlier this week that said it recently made a takeover approach to Boston Scientific.

Stocks Rise Cautiously Ahead of Trump-Kim Meeting

Stocks Rise Cautiously Ahead of Trump-Kim Meeting

Stocks closed higher on Monday as Wall Street prepares for an extraordinary week for risk events around the world.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The major U.S. averages closed the day in the green Monday.

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Jim Cramer and our other experts discuss Trump and stocks, trade, and pajama trading.

Boston Scientific Jumps on Report of Stryker Takeover Approach

Boston Scientific Jumps on Report of Stryker Takeover Approach

The Wall Street Journal reports Stryker made a takeover approach for the medical device company.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMCX, APAM, BEAT, BSX, CIO, CRZO, EFII, FNB, LNDC, NTWK, OXSQ, SIR, VOC, WHG Downgrades: ABEV, ARNC, BMS, EMCI, ERII, ESGR, ESLT, GASS, IVZ, LPL, PICO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

TheStreet Quant Rating: B (Buy)